Clinical Trials Logo

Clinical Trial Summary

Interventional study designed for the evaluation of characters and the outcome of scorpion sting patients will admit to Sohag University Hospitals in 2 randomized groups. The first group will receive scorpion antivenom only whether by the intravenous or the intramuscular route of administration. The second group will receive a combination of prazosin plus scorpion antivenom whether by the intravenous or the intramuscular route of administration. Both groups will receive proper first aid and supportive treatment


Clinical Trial Description

Tools of the study: 1. Dose and administration of prazosin: 30 μg/kg/dose of prazosin will be delivered orally every 6 hours 4 doses, in adults we shouldn't exceed 1 mg per dose. Prazosin will be delivered using a nasogastric tube while securing the patient's airway in the event of vomiting or unconsciousness. Every 30 minutes for the first three hours, every hour for the following six, and then every four hours until improvement, blood pressure, pulse rate, respiration rate, and oxygen saturation will be measured. When pain is the only symptom, prophylaxis shouldn't be given. To avoid the first-dose phenomenon, the patient should remain in a laying position for around 3 hours (even while the case is being examined) (Shoreit et al., 2019). Dose of antivenom 1-1 ampoule intramuscular and/ or, 2-1 to 5 Polyvalent anti-scorpion serum ampoules produced by the vaccine & serum institution (VACSERA)in Egypt according to the severity of the case on 200 to 500 ml glucose 5% infusion and assess the patient clinically to repeat the dose after 4 to 6 hours. (Shoreit et al., 2019) 2. A prepared sheet containing 1. the demographic characteristics of each patient 2. Vital signs and degree of coma at time of admission of the patient. 3. First aid management as resuscitation. 4. Supportive management will be done to the patients during the admission will be recorded. 5. Cardiac enzymes measurements, duration of hospital stay and the outcome of patients in each group. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06287905
Study type Interventional
Source Sohag University
Contact Meray M Shokry Zaghary, PhD
Phone +201028911003
Email drevanho2013@gmail.com
Status Recruiting
Phase Phase 4
Start date February 1, 2023
Completion date July 1, 2024

See also
  Status Clinical Trial Phase
Completed NCT03079726 - Use of Device Data to Predict Frailty in Individuals
Not yet recruiting NCT05447611 - Role of Empathy in Curative Treatment Outcomes of Non-metastatic Colorectal Cancer.
Completed NCT05268419 - Efficacy and Safety of Ethanol Inhalation on COVID-19 Treatment (a Clinical Trial Study) Phase 3
Completed NCT05042804 - Perioperative Outcome Risk Assessment With Computer Learning Enhancement N/A
Recruiting NCT03628313 - Valvular Aortic Stenosis Prognosis Study
Completed NCT05527678 - 5 Years Quality of Life and Early Mobilization in ICU
Recruiting NCT05088109 - Shock Indices Use for Early Mortality From Septic Shock
Recruiting NCT05073991 - Incidence of Mortality and Complications After Lung Surgery, Open Thoracic Aortic Repair, TEVAR, EVAR.
Completed NCT05844410 - Evaluation of Corticosteroids Use and Clinical Outcomes in Hospitalized COVID-19 Patients: A Retrospective Study
Recruiting NCT05585593 - Registry for Hypoparathyroidism Wuerzburg
Recruiting NCT03834246 - Smoke Inhalation Injury in Patients Admitted to Intensive Care
Completed NCT03919032 - Bacterial Infections in Patients With Cirrhosis in Argentina: Clinical and Microbiological Characteristics
Completed NCT05116670 - Comparison of Care Practices, Mortality and Morbidity of Very Preterm Infants Between Two Tertiary Centers in Northwest and South of China
Withdrawn NCT04531839 - Improving Outcome of Very Preterm Infants Using Collaborative Quality Improvement N/A
Recruiting NCT04685278 - Anticardiolipin Autoantibodies and Mortality in Septic Patients
Not yet recruiting NCT03665987 - The Effect of Preoperative Assessment Clinic on Prognosis and Economic Results of Patients With Coexisting Disease.
Completed NCT04049565 - CRP Versus PCT as Bio-markers for Sepsis and in Guiding Antibiotics in Critically Ill Patients
Completed NCT04971278 - Evaluating the Impact of a Supportive Care Program
Recruiting NCT06087315 - Evaluation of a Multi-country Medical Oxygen Program
Completed NCT03344627 - Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients N/A